Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients without prior polymerase chain reaction–confirmed COVID-
19 were recruited from across the US to participate in this prospective cohort through a …

Foot strike patterns and collision forces in habitually barefoot versus shod runners

DE Lieberman, M Venkadesan, WA Werbel, AI Daoud… - Nature, 2010 - nature.com
Humans have engaged in endurance running for millions of years 1, but the modern running
shoe was not invented until the 1970s. For most of human evolutionary history, runners were …

Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients across the US were recruited though social media to
participate in this prospective cohort, and those who underwent SARS-CoV-2 vaccination …

Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series

WA Werbel, BJ Boyarsky, MT Ou… - Annals of internal …, 2021 - acpjournals.org
Background: The antibody response after 2 doses of an mRNA vaccine against SARS-CoV-
2 is excellent in the general population (1), but the response is different in recipients of solid …

Early impact of COVID‐19 on transplant center practices and policies in the United States

BJ Boyarsky, T Po‐Yu Chiang… - american Journal of …, 2020 - Wiley Online Library
COVID‐19 is a novel, rapidly changing pandemic: consequently, evidence‐based
recommendations in solid organ transplantation (SOT) remain challenging and unclear. To …

Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients

CX Qin, LW Moore, S Anjan, R Rahamimov… - …, 2021 - journals.lww.com
All authors participated in conception or design of the work or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising it critically for important …

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

BJ Boyarsky, JA Ruddy, CM Connolly, MT Ou… - Annals of the …, 2021 - ard.bmj.com
The immune response to SARS-CoV-2 messenger RNA (mRNA) vaccines in patients with
rheumatic and musculoskeletal diseases (RMD) is undefined because these individuals …

Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two‐dose SARS–CoV‐2 messenger RNA vaccination

CM Connolly, JA Ruddy, BJ Boyarsky… - Arthritis & …, 2022 - Wiley Online Library
Objective To evaluate disease flare and postvaccination reactions (reactogenicity) in
patients with rheumatic and musculoskeletal diseases (RMDs) following 2‐dose SARS–CoV …

Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series

JL Alejo, J Mitchell, TPY Chiang, AT Abedon… - …, 2021 - journals.lww.com
The antibody response after 2 doses of an mRNA severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine is excellent in the general population but less robust in …

A third dose of SARS‐CoV‐2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

AH Karaba, X Zhu, T Liang, KH Wang… - American Journal of …, 2022 - Wiley Online Library
Abstract Vaccine‐induced SARS‐CoV‐2 antibody responses are attenuated in solid organ
transplant recipients (SOTRs) and breakthrough infections are more common. Additional …